1. CONy16: MS Researchers Question Possible Long-term Benefits of Remyelination Therapies
“Multiple sclerosis was a main focus at the four-day 10th World Congress on Controversies in Neurology (CONy), in Lisbon, Portugal, that concluded on March 20. Among the topics of debate was demyelination as the disease’s main pathogenic precursor and the clinical potential of remyelination.”
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?